Furthermore, since anti-tumor property of IL-24 was dose-dependent, we also chose two different concentration (10 ng/ml as low concentration and 100 ng/ml as high concentration) of recombinant IL-24 for stimulation based on the plasma IL-24 level in colorectal adenocarcinoma patients and healthy individuals. This evidence concerns the gene IL24 and neoplasm.